Magnetic resonance imaging and spectroscopy in hypomyelinating leukodystrophy

Area of Science:

• Molecular Biology
• Radiology
• Neurology

Background:

• Leukodystrophies are white matter disorders identified through advancements in molecular biology and radiology.
• Key diagnostic feature: increased white matter signal intensity on T2-weighted MRI.
• Classified into hypomyelinating leukodystrophies (HLD) and demyelinating forms.

Purpose of the Study:

• Provide an overview of the latest imaging findings and clinical features of HLD.
• Highlight diagnostic distinctions between HLD and other leukodystrophies.
• Emphasize the role of MR spectroscopy in HLD diagnosis.

Main Methods:

• Review of recent advancements in molecular biology and radiology.
• Analysis of T2-weighted MRI findings in leukodystrophies.
• Evaluation of MR spectroscopy data, specifically N-acetylaspartate levels.

Main Results:

• HLD results from genetic variants affecting myelin structure, oligodendrocyte function, and lysosomal pathways.
• Radiologically, HLD shows less T2-weighted white matter hyperintensity compared to demyelinating forms.
• Normal N-acetylaspartate levels on MR spectroscopy are a distinctive feature of HLD.

Conclusions:

• HLD diagnosis is supported by imaging beyond white matter (basal ganglia, cerebellum) and clinical symptoms.
• Normal N-acetylaspartate levels differentiate HLD from other neurological conditions.
• Integrated molecular, radiological, and clinical data are crucial for accurate HLD diagnosis.